| Term | Count | % | | DRUG INEFFECTIVE | 4055 | 9.13% |
| TREATMENT FAILURE | 3076 | 6.93% |
| OCULAR HYPERAEMIA | 2321 | 5.23% |
| EYE IRRITATION | 1824 | 4.11% |
| MADAROSIS | 1383 | 3.11% |
| EYE PRURITUS | 1313 | 2.96% |
| ERYTHEMA OF EYELID | 1009 | 2.27% |
| EYE PAIN | 926 | 2.09% |
| HYPERSENSITIVITY | 850 | 1.91% |
| VISION BLURRED | 828 | 1.86% |
| INTRAOCULAR PRESSURE INCREASED | 709 | 1.60% |
| FATIGUE | 688 | 1.55% |
| OFF LABEL USE | 685 | 1.54% |
| HEADACHE | 654 | 1.47% |
| DRY EYE | 643 | 1.45% |
| EYE SWELLING | 643 | 1.45% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 582 | 1.31% |
| INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION | 539 | 1.21% |
| DYSPNOEA | 534 | 1.20% |
| EYELIDS PRURITUS | 529 | 1.19% |
| ERYTHEMA | 510 | 1.15% |
| DIZZINESS | 509 | 1.15% |
| NAUSEA | 494 | 1.11% |
| DIARRHOEA | 489 | 1.10% |
| INCORRECT DOSE ADMINISTERED | 488 | 1.10% |
| SKIN HYPERPIGMENTATION | 480 | 1.08% |
| FALL | 452 | 1.02% |
| VISUAL IMPAIRMENT | 451 | 1.02% |
| ASTHENIA | 435 | 0.98% |
| EYELID OEDEMA | 419 | 0.94% |
| PRURITUS | 416 | 0.94% |
| WRONG TECHNIQUE IN DRUG USAGE PROCESS | 404 | 0.91% |
| PAIN | 387 | 0.87% |
| DEATH | 375 | 0.84% |
| LACRIMATION INCREASED | 372 | 0.84% |
| EYELID IRRITATION | 370 | 0.83% |
| PRODUCT DOSE OMISSION ISSUE | 349 | 0.79% |
| RASH | 346 | 0.78% |
| CATARACT | 329 | 0.74% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 323 | 0.73% |
| GLAUCOMA | 316 | 0.71% |
| MALAISE | 313 | 0.70% |
| EYE DISCHARGE | 304 | 0.68% |
| THERAPEUTIC RESPONSE DECREASED | 298 | 0.67% |
| GROWTH OF EYELASHES | 295 | 0.66% |
| SKIN DISCOLOURATION | 290 | 0.65% |
| VISUAL ACUITY REDUCED | 285 | 0.64% |
| PNEUMONIA | 281 | 0.63% |
| TRICHORRHEXIS | 281 | 0.63% |
| BLEPHARAL PIGMENTATION | 279 | 0.63% |
| DRUG DOSE OMISSION | 272 | 0.61% |
| ARTHRALGIA | 270 | 0.61% |
| VOMITING | 267 | 0.60% |
| PAIN IN EXTREMITY | 262 | 0.59% |
| COUGH | 259 | 0.58% |
| DRUG HYPERSENSITIVITY | 255 | 0.57% |
| WEIGHT DECREASED | 250 | 0.56% |
| ACCIDENTAL EXPOSURE TO PRODUCT | 246 | 0.55% |
| INSOMNIA | 241 | 0.54% |
| PRODUCT QUALITY ISSUE | 236 | 0.53% |
| HYPERTENSION | 234 | 0.53% |
| EYE DISORDER | 218 | 0.49% |
| FOREIGN BODY SENSATION IN EYES | 212 | 0.48% |
| DECREASED APPETITE | 204 | 0.46% |
| CONSTIPATION | 196 | 0.44% |
| BLOOD PRESSURE INCREASED | 194 | 0.44% |
| BACK PAIN | 193 | 0.43% |
| OCULAR DISCOMFORT | 193 | 0.43% |
| PRODUCT PACKAGING QUANTITY ISSUE | 190 | 0.43% |
| GAIT DISTURBANCE | 187 | 0.42% |
| HAIR GROWTH ABNORMAL | 187 | 0.42% |
| ANAEMIA | 184 | 0.41% |
| ANXIETY | 183 | 0.41% |
| HYPOTENSION | 176 | 0.40% |
| CONDITION AGGRAVATED | 174 | 0.39% |
| PHOTOPHOBIA | 173 | 0.39% |
| PYREXIA | 172 | 0.39% |
| FEELING ABNORMAL | 169 | 0.38% |
| URINARY TRACT INFECTION | 168 | 0.38% |
| DEPRESSION | 157 | 0.35% |
| CONFUSIONAL STATE | 156 | 0.35% |
| PERIPHERAL SWELLING | 154 | 0.35% |
| SOMNOLENCE | 153 | 0.34% |
| SWELLING OF EYELID | 153 | 0.34% |
| EXPIRED PRODUCT ADMINISTERED | 152 | 0.34% |
| MYALGIA | 152 | 0.34% |
| BLINDNESS | 150 | 0.34% |
| ABDOMINAL DISCOMFORT | 149 | 0.34% |
| EYELID PAIN | 149 | 0.34% |
| CHEST PAIN | 148 | 0.33% |
| DRUG ADMINISTERED AT INAPPROPRIATE SITE | 148 | 0.33% |
| OEDEMA PERIPHERAL | 147 | 0.33% |
| ALOPECIA | 144 | 0.32% |
| CEREBROVASCULAR ACCIDENT | 144 | 0.32% |
| NASOPHARYNGITIS | 144 | 0.32% |
| ATRIAL FIBRILLATION | 141 | 0.32% |
| BLEPHARITIS | 141 | 0.32% |
| BLOOD GLUCOSE INCREASED | 141 | 0.32% |
| ABDOMINAL PAIN UPPER | 140 | 0.32% |
| BURNING SENSATION | 140 | 0.32% |
| Total | 44399 | |